Carnegie Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MUDS
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
|
+$10.3M |
| 2 |
Shoals Technologies Group
SHLS
|
+$6.57M |
| 3 |
Array Technologies
ARRY
|
+$5.42M |
| 4 |
Guardant Health
GH
|
+$4.63M |
| 5 |
BSCP
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
|
+$4.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSCL
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
|
+$7.42M |
| 2 |
Carvana
CVNA
|
+$6.06M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$3.47M |
| 4 |
Beyond Meat
BYND
|
+$3.14M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$2.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 13.39% |
| 3 | Healthcare | 10.89% |
| 4 | Industrials | 9.73% |
| 5 | Consumer Discretionary | 9.32% |
Similar funds
Carnegie Investment Counsel's Q2 2021 Portfolio in Review
As of Q2 2021, Carnegie Investment Counsel held 487 positions worth $2.65B, up 11% from $2.39B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Carnegie Investment Counsel deployed $82.9M of net new capital in Q2 2021, opening 33 new positions and adding to 237 existing holdings. Its largest new stake was Mudrick Capital Acquisition Corporation II Class A Common Stock: 792,400 shares worth $9.87M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco BulletShares 2021 Corporate Bond ETF, an estimated $7.42M trimmed.
- Carnegie Investment Counsel's largest Q2 2021 buy was Mudrick Capital Acquisition Corporation II Class A Common Stock: 792,400 shares worth $9.87M.
- Carnegie Investment Counsel added most to Array Technologies in Q2 2021, an estimated $5.42M increase.
- Carnegie Investment Counsel's biggest Q2 2021 reduction was Invesco BulletShares 2021 Corporate Bond ETF, cutting an estimated $7.42M.
- Carnegie Investment Counsel fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $2.99M.
- Carnegie Investment Counsel's ten largest holdings make up 21% of its $2.65B portfolio in Q2 2021.
- Carnegie Investment Counsel opened 33 new positions and closed 15 in Q2 2021.
- Carnegie Investment Counsel's portfolio value rose 11% quarter-over-quarter to $2.65B.
Based on Carnegie Investment Counsel's 13F filing for Q2 2021, filed 16 Jul 2021.